Cited by 2.1kOpen Access
Howard Hughes Medical Institute
ORCID: 0000-0002-0000-0452Publishes on Immune Cell Function and Interaction, T-cell and B-cell Immunology, IL-33, ST2, and ILC Pathways. 165 papers and 18.9k citations.
Add your photo, update your bio, and get notified when your ranking changes.
The cytokine transforming growth factor-beta (TGF-beta) converts naïve T cells into regulatory T (Treg) cells that prevent autoimmunity. However, in the presence of interleukin-6 (IL-6), TGF-beta has also been found to promote the differentiation of naïve T lymphocytes into proinflammatory IL-17 cytokine-producing T helper 17 (T(H)17) cells, which promote autoimmunity and inflammation. This raises the question of how TGF-beta can generate such distinct outcomes. We identified the vitamin A metabolite retinoic acid as a key regulator of TGF-beta-dependent immune responses, capable of inhibiting the IL-6-driven induction of proinflammatory T(H)17 cells and promoting anti-inflammatory Treg cell differentiation. These findings indicate that a common metabolite can regulate the balance between pro- and anti-inflammatory immunity.